✦ LIBER ✦

Phase II study of weekly topotecan in patients with recurrent or persistent epithelial ovarian cancer

✍ Scribed by Tally Levy; Moshe Inbar; Joseph Menczer; Dan Grisaru; Marek Glezerman; Tamar Safra

Book ID: 113959568
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 140 KB
Volume: 95
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2004.09.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of weekly topotecan in pat

Effectiveness of weekly topotecan in patients with recurrent epithelial ovarian cancer

✍ I. VANDENPUT; F. AMANT; P. NEVEN; P. BERTELOOT; K. LEUNEN; I. VERGOTE 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

A Phase I/II Study of Topotecan in Combi

A Phase I/II Study of Topotecan in Combination with Carboplatin in Recurrent Epithelial Ovarian Cancer

✍ Giorgio Bolis; Giovanna Scarfone; Cesarina Sciatta; Gian Piero Polverino; Cristi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 40 KB

A phase II study of weekly topotecan and

A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers

✍ Divya Gupta; Ricky L. Owers; Mimi Kim; Dennis Yi-Shin Kuo; Gloria S. Huang; Shoh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Weekly combination of topotecan and gemc

Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: A French multicenter phase II study

✍ F. Joly; T. Petit; P. Pautier; E. Guardiola; F. Mayer; A. Chevalier-Place; R. De 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 403 KB

Topotecan combined with carboplatin in r

Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: Results of a single-institutional phase II study

✍ Heeseok Kang; Tae-Joong Kim; Yoo-Young Lee; Chel Hun Choi; Jeong-Won Lee; Duk-So 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 235 KB

A phase II and pharmacodynamic study of

A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer

✍ Edwin M. Posadas; Meghan S. Liel; Virginia Kwitkowski; Lori Minasian; Andrew K. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 2 views

## Abstract ## BACKGROUND The primary objective of this study was to evaluate the biochemical effects of gefitinib on its target signal‐transduction pathways in patients with recurrent epithelial ovarian cancer (EOC). The secondary objectives included assessing clinical activity and toxicity and d